This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.
In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.
In your application messsage, please share your background and what you can contribute to the group.
Company Overview and News
This puts to rest speculation as to whether the CEP, led by the 80-year Tun Daim Zainuddin would continue to chart the path of government linked companies (GLCs) and its parent companies, which are the government linked investment companies (GLICs).
1023 1171 CIMDF
KUALA LUMPUR (Aug 3): Khazanah Nasional Bhd has appointed Datuk Shahril Ridza Ridzuan, currently the chief executive officer (CEO) of the Employees Provident Fund (EPF), as managing director (MD) of the sovereign wealth fund effective Aug 20.
4502 MIAHF 1171
Malaysia Building Society Bhd (July 31, RM1.12) Maintain hold with a lower fair value (FV) of RM1.27: Malaysia Building Society Bhd’s (MBSB) net profit for the second quarter of financial year 2018 (2QFY18) fell 71.8% quarter-on-quarter (q-o-q) due to a charge in impairment allowances for loans of RM124 milliion compared to a net write-back in provisions of RM154 million in 1QFY18, and higher operating expenses (Opex) from integration cost and amortisation of information technology (IT) investments.
KUALA LUMPUR: Malaysia Building Society Bhd (MBSB) saw its net profit fall 5.9% to RM85.69 million in the second quarter ended June 30, 2018 (2QFY18) from RM91.08 million a year ago, on lower gross loans and financing for 2QFY18.
1171 BSMAF 1818
KUALA LUMPUR (July 31): Malaysia Building Society Bhd (MBSB) shares fell as much as four sen or 3% so far today after the financial services provider said yesterday second quarter net profit dropped to RM85.69 million from RM91.08 million a year earlier.
1171 BSMAF 1818
KUALA LUMPUR (July 30): Based on corporate announcements and news flow today, companies in focus on Tuesday (July 31) may include: Top Glove Corp Bhd, JAKS Resources Bhd, Star Media Group Bhd, Malaysia Building Society Bhd, Barakah Offshore Petroleum Bhd, Handal Resources Bhd, Fima Corp Bhd, Datasonic Group Bhd, New Hoong Fatt Holdings Bhd, Rev Asia Bhd and Tadmax Resources Bhd
6084 7251 7060 7113 TPGVF 1171 0173 7253 4022 TGLVY 5216 4723 WWDH
KUALA LUMPUR (July 30): Malaysia Building Society Bhd (MBSB) saw its net profit fall 5.9% to RM85.69 million in the second quarter ended June 30, 2018 (2QFY18) from RM91.08 million a year ago, on lower gross loans and financing for 2QFY18.
1171 BSMAF 1818
2018-07-26 theedgemarkets - 1
AFTER the 1997/98 Asian financial crisis that wreaked havoc on Asian currencies and equities, the government created agencies like Danaharta and the Corporate Debt Restructuring Committee (CDRC) to rescue and restructure various companies that owned assets deemed to be of strategic and national importance.
MLYBY MLYNF 4197 8664 1171 CIMDF 1155 1023 5347 5225 SMEBF TNABY 6888 AXXTF TNABF Q0F BSMAF IHHHF 1818
THE ringgit, which last week breached the psychological RM4 mark against the US dollar for the first time in five months, is in the spotlight again. At the time of writing last Friday (June 22), the ringgit fetched 4.0022 against the greenback. The ringgit’s fair value should be 3.80, Prime Minister Tun Dr Mahathir Mohamad told Bloomberg in a June 22 interview. “We would like to strengthen our ringgit, but it should be done naturally,” he said.
SARKF MLYNF 8664 6521 7237 1171 5158 8583 0012 4898 3883 5126 7229 SMEBF 5703 MYTEF MLYBY 4197 5202 7164 5222 1155 4588 4863 3158 4723
3h - Asif
Overview Recro Pharma is a specialty pharmaceutical company that operates through two business divisions: an Acute Care division and a revenue-generating CDMO division. Each of these divisions are deemed to be reportable segments for financial reporting purposes. The company's Acute Care segment is primarily focused on developing and commercializing innovative products for hospital and related acute care settings. The company's lead product candidate is a proprietary injectable form of meloxicam, a long-acting preferential COX-2 inhibitor. IV meloxicam has successfully completed three Phase III clinical trials for the management of moderate to severe pain, consisting of two pivotal efficacy trials and a large double-blind Phase III safety trial, as well as other safety studies. Overall, the total new drug application, or NDA, program included over 1,400 patients. In late July 2017, the company submitted a NDA to the U.S. Food and Drug Administration, or FDA, for IV meloxicam...
3h - Asif
Overview Achillion Pharmaceuticals is a clinical-stage biopharmaceutical company focused on advancing its oral factor D inhibitors into late-stage development and commercialization. Each of the drug candidates in its oral factor D portfolio was discovered in its laboratories and is wholly owned by it. Achillion Pharmaceuticals is focusing its drug development activities on alternative pathway-mediated, rare diseases where there are no approved therapies or where existing therapies are inadequate for patients. To advance its investigational drugs into phase III and commercialization, the company plan to work closely with key stakeholders including patients, payors, regulators and healthcare professionals. The company's first-generation factor D inhibitor, ACH-4471, has demonstrated preliminary clinical proof-of-concept in patients with C3 glomerulopathy, or C3G, a disease affecting the kidney, and paroxysmal nocturnal hemoglobinuria, or PNH, a blood disorder, and has advanced...
4h - Asif
General Baytex Energy Corp. was incorporated on October 22, 2010 pursuant to the provisions of the ABCA. Baytex is the successor to the business of Baytex Energy Trust, which was transitioned to Baytex on December 31, 2010. Inter-Corporate Relationships The following table provides the name, the percentage of voting securities owned by it and the jurisdiction of incorporation, continuance, formation or organization of its material subsidiaries either, direct and indirect, as at the date hereof. ||Percentage of voting securities (directly or indirectly)|Jurisdiction of Incorporation/Formation| | ------------ | ------------: | :------------: | |Baytex Energy Ltd.|100%|Alberta| |Baytex Energy USA, Inc.|100%|Delaware| |Baytex Energy Partnership|100%|Alberta| Organizational Structure The following simplified diagram shows the inter-corporate relationships among it and its material subsidiaries as of the date hereof. <img src="https://www.sec.gov/A...